BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34031403)

  • 1. Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase.
    Hayes RP; Heo MR; Mason M; Reid J; Burlein C; Armacost KA; Tellers DM; Raheem I; Shaw AW; Murray E; McKenna PM; Abeywickrema P; Sharma S; Soisson SM; Klein D
    Nat Commun; 2021 May; 12(1):3040. PubMed ID: 34031403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the herpes simplex virus 1 DNA polymerase.
    Liu S; Knafels JD; Chang JS; Waszak GA; Baldwin ET; Deibel MR; Thomsen DR; Homa FL; Wells PA; Tory MC; Poorman RA; Gao H; Qiu X; Seddon AP
    J Biol Chem; 2006 Jun; 281(26):18193-200. PubMed ID: 16638752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.
    Brideau RJ; Knechtel ML; Huang A; Vaillancourt VA; Vera EE; Oien NL; Hopkins TA; Wieber JL; Wilkinson KF; Rush BD; Schwende FJ; Wathen MW
    Antiviral Res; 2002 Apr; 54(1):19-28. PubMed ID: 11888654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase.
    Topalis D; Gillemot S; Snoeck R; Andrei G
    Nucleic Acids Res; 2016 Nov; 44(20):9530-9554. PubMed ID: 27694307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
    Schnute ME; Anderson DJ; Brideau RJ; Ciske FL; Collier SA; Cudahy MM; Eggen M; Genin MJ; Hopkins TA; Judge TM; Kim EJ; Knechtel ML; Nair SK; Nieman JA; Oien NL; Scott A; Tanis SP; Vaillancourt VA; Wathen MW; Wieber JL
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3349-53. PubMed ID: 17434304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.
    Hartline CB; Harden EA; Williams-Aziz SL; Kushner NL; Brideau RJ; Kern ER
    Antiviral Res; 2005 Feb; 65(2):97-105. PubMed ID: 15708636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure and function of the HSV DNA replication proteins: defining novel antiviral targets.
    Matthews JT; Terry BJ; Field AK
    Antiviral Res; 1993 Feb; 20(2):89-114. PubMed ID: 8384825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
    Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation in the DNA polymerase accessory factor of herpes simplex virus 1 restores viral DNA replication in the presence of raltegravir.
    Zhou B; Yang K; Wills E; Tang L; Baines JD
    J Virol; 2014 Oct; 88(19):11121-9. PubMed ID: 25008933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
    Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
    J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA.
    Vashishtha AK; Kuchta RD
    Biochemistry; 2016 Feb; 55(7):1168-77. PubMed ID: 26836009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A.
    Grover A; Agrawal V; Shandilya A; Bisaria VS; Sundar D
    BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S22. PubMed ID: 22373101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.
    DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK
    mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pre-NH(2)-terminal domain of the herpes simplex virus 1 DNA polymerase catalytic subunit is required for efficient viral replication.
    Terrell SL; Coen DM
    J Virol; 2012 Oct; 86(20):11057-65. PubMed ID: 22875965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors.
    Oien NL; Brideau RJ; Hopkins TA; Wieber JL; Knechtel ML; Shelly JA; Anstadt RA; Wells PA; Poorman RA; Huang A; Vaillancourt VA; Clayton TL; Tucker JA; Wathen MW
    Antimicrob Agents Chemother; 2002 Mar; 46(3):724-30. PubMed ID: 11850254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nucleoside inhibitors of herpesviruses.
    Wathen MW
    Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1.
    Tian W; Hwang YT; Lu Q; Hwang CB
    J Virol; 2009 Jul; 83(14):7194-201. PubMed ID: 19420083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.